Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-26T21:04:14.227Z Has data issue: false hasContentIssue false
  • English
  • Français

Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity

Published online by Cambridge University Press:  26 January 2019

Jonathan H Soslow ,
Matthew Hall ,
W Bryan Burnette ,
Kan Hor ,
Joanne Chisolm ,
Christopher Spurney ,
Justin Godown ,
Meng Xu ,
James C Slaughter  and
Larry W Markham
Jonathan H Soslow*
Affiliation:
Thomas P Graham Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
Matthew Hall
Affiliation:
Children’s Hospital Association, Lenexa, KS, USA
W Bryan Burnette
Affiliation:
Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
Kan Hor
Affiliation:
Division of Pediatric Cardiology, Nationwide Children’s Hospital and The Ohio State University, Columbus, OH, USA
Joanne Chisolm
Affiliation:
Division of Pediatric Cardiology, Nationwide Children’s Hospital and The Ohio State University, Columbus, OH, USA
Christopher Spurney
Affiliation:
Division of Cardiology, Children’s National Heart Institute, Children’s National Health System, Washington, DC, USA
Justin Godown
Affiliation:
Thomas P Graham Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
Meng Xu
Affiliation:
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA
James C Slaughter
Affiliation:
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA
Larry W Markham
Affiliation:
Thomas P Graham Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA Division of Cardiology, Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA
*
Author for correspondence: J. H. Soslow, MD, MSCI, Assistant Professor, Pediatrics, Thomas P. Graham, Jr. Division of Pediatric Cardiology, Monroe Carell Jr. Children’s Hospital at Vanderbilt, 2200 Children’s Way, Suite 5230, Doctors’ Office Tower, Nashville, TN 37232-9119, USA. Tel: +1-615-322-7447; Fax: +1-615-322-2210; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Outcome analyses in large administrative databases are ideal for rare diseases such as Becker and Duchenne muscular dystrophy. Unfortunately, Becker and Duchenne do not yet have specific International Classification of Disease-9/-10 codes. We hypothesised that an algorithm could accurately identify these patients within administrative data and improve assessment of cardiovascular morbidity.

Methods

Hospital discharges (n=13,189) for patients with muscular dystrophy classified by International Classification of Disease-9 code: 359.1 were identified from the Pediatric Health Information System database. An identification algorithm was created and then validated at three institutions. Multi-variable generalised linear mixed-effects models were used to estimate the associations of length of stay, hospitalisation cost, and 14-day readmission with age, encounter severity, and respiratory disease accounting for clustering within the hospital.

Results

The identification algorithm improved identification of patients with Becker and Duchenne from 55% (code 359.1 alone) to 77%. On bi-variate analysis, left ventricular dysfunction and arrhythmia were associated with increased cost of hospitalisation, length of stay, and mortality (p<0.001). After adjustment, Becker and Duchenne patients with left ventricular dysfunction and arrhythmia had increased length of stay with rate ratio 1.4 and 1.2 (p<0.001 and p=0.004) and increased cost of hospitalization with rate ratio 1.4 and 1.4 (both p<0.001).

Conclusions

Our algorithm accurately identifies patients with Becker and Duchenne and can be used for future analysis of administrative data. Our analysis demonstrates the significant effects of cardiovascular disease on length of stay and hospitalisation cost in patients with Becker and Duchenne. Better recognition of the contribution of cardiovascular disease during hospitalisation with earlier more intensive evaluation and therapy may help improve outcomes in this patient population.

Keywords

Duchenne muscular dystrophyBecker muscular dystrophyPediatric Health Information Systemleft ventricular dysfunctionarrhythmiacardiomyopathy
Type
Original Article
Information
Cardiology in the Young , Volume 29 , Issue 3 , March 2019 , pp. 290 - 296
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. (2019) Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiology in the Young29: 290–296. doi: 10.1017/S1047951118002226

References

1. Dooley, J, Gordon, KE, Dodds, L, MacSween, J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr (Phila) 2010; 49: 177–179.Google Scholar
2. Bushby, KM, Thambyayah, M, Gardner-Medwin, D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991; 337: 1022–1024.Google Scholar
3. Moser, H. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet 1984; 66: 17–40.Google Scholar
4. Hoffman, EP, Brown, RH Jr., Kunkel, LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919–928.Google Scholar
5. Nigro, G, Comi, LI, Politano, L, Bain, RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990; 26: 271–277.Google Scholar
6. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005; 116: 1569–1573.Google Scholar
7. Eagle, M, Baudouin, SV, Chandler, C, Giddings, DR, Bullock, R, Bushby, K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12: 926–929.Google Scholar
8. Bach, JR, Martinez, D. Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respir Care 2011; 56: 744–750.Google Scholar
9. Punnoose, AR, Kaltman, JR, Pastor, W, McCarter, R, He, J, Spurney, CF. Cardiac disease burden and risk of mortality in hospitalized muscular dystrophy patients. Pediatr Cardiol 2016; 37: 1290–1296.Google Scholar
10. Connuck, DM, Sleeper, LA, Colan, SD, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 2008; 155: 998–1005.Google Scholar
11. Spurney, C, Shimizu, R, Morgenroth, LP, et al. Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 2014; 50: 250–256.Google Scholar
12. Eagle, M, Bourke, J, Bullock, R, et al. Managing Duchenne muscular dystrophy—the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord 2007; 17: 470–475.Google Scholar
13. Thayer, S, Bell, C, McDonald, CM. The direct cost of managing a rare disease: assessing medical and pharmacy costs associated with Duchenne muscular dystrophy in the United States. J Manag Care Spec Pharm 2017; 23: 633–641.Google Scholar
14. Teoh, LJ, Geelhoed, EA, Bayley, K, Leonard, H, Laing, NG. Health care utilization and costs for children and adults with duchenne muscular dystrophy. Muscle Nerve 2016; 53: 877–884.Google Scholar
15. Schreiber-Katz, O, Klug, C, Thiele, S, et al. Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany. Orphanet J Rare Dis 2014; 9: 210.Google Scholar
16. Landfeldt, E, Lindgren, P, Bell, CF, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology 2014; 83: 529–536.Google Scholar
17. Bach, JR, Tran, J, Durante, S. Cost and physician effort analysis of invasive vs. noninvasive respiratory management of Duchenne muscular dystrophy. Am J Phys Med Rehabil 2015; 94: 474–482.Google Scholar
Supplementary material: File

Soslow et al. supplementary material

Table S1

Download Soslow et al. supplementary material(File)
File 98 KB
Supplementary material: File

Soslow et al. supplementary material

Tables S2A-C

Download Soslow et al. supplementary material(File)
File 18 KB
Supplementary material: File

Soslow et al. supplementary material

Table S3

Download Soslow et al. supplementary material(File)
File 20 KB
Supplementary material: File

Soslow et al. supplementary material

Table S4

Download Soslow et al. supplementary material(File)
File 15 KB